{"id":104088,"date":"2018-01-01T12:00:00","date_gmt":"2018-01-01T12:00:00","guid":{"rendered":"https:\/\/www.transcend.org\/tms\/?p=104088"},"modified":"2017-12-29T12:20:27","modified_gmt":"2017-12-29T12:20:27","slug":"life-saving-cancer-drug-sees-1400-price-hike","status":"publish","type":"post","link":"https:\/\/www.transcend.org\/tms\/2018\/01\/life-saving-cancer-drug-sees-1400-price-hike\/","title":{"rendered":"Life-Saving Cancer Drug Sees 1400% Price Hike"},"content":{"rendered":"<blockquote><p><em>The potentially life-saving medicine is used to treat patients suffering from brain tumors and Hodgkin&#8217;s lymphoma.<\/em><\/p><\/blockquote>\n<div id=\"attachment_104089\" style=\"width: 410px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2017\/12\/medication-pill-pharma-health.jpg\" ><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-104089\" class=\"wp-image-104089\" src=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2017\/12\/medication-pill-pharma-health.jpg\" alt=\"\" width=\"400\" height=\"227\" srcset=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2017\/12\/medication-pill-pharma-health.jpg 600w, https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2017\/12\/medication-pill-pharma-health-300x170.jpg 300w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/a><p id=\"caption-attachment-104089\" class=\"wp-caption-text\">The price hike is seen as a concern for those may now no longer be able to afford it. | Photo: Reuters<\/p><\/div>\n<p><em>27 Dec 2017 &#8211; <\/em>The price of the cancer drug lomustine has soared to nearly 1400 percent since 2013, after it was bought by a startup in Miami, U.S.<\/p>\n<blockquote><p><strong><em>RELATED:\u00a0<\/em><\/strong><em><a target=\"_blank\" href=\"http:\/\/www.telesurtv.net\/english\/news\/Brazil-Provides-Free-Antiretroviral-Drug-to-Combat-HIV-Crisis-20171212-0035.html\" >Brazil Provides Free Antiretroviral Drug to Combat HIV Crisis<\/a><\/em><\/p><\/blockquote>\n<p>While originally sold by Bristol-Myers Squib for decades under the brand name CeeNU for about US$50 a capsule, it now goes for US$768 per pill, thanks to startup NextSource\u2019s price hikes.<\/p>\n<p>According to Henry S. Friedman, a professor of neurosurgery at Duke University School of Medicine, NextSource has engaged in \u201cprice-gouging\u201d, telling the Wall Street Journal, &#8220;People are not going to be able to afford it, or they&#8217;re going to pay a lot of money and have financial liability.\u201d<\/p>\n<p>The medicine is used to treat patients suffering from brain tumors and Hodgkin&#8217;s lymphoma, and can be potentially life-saving.<\/p>\n<p>NextSource CEO Robert DiCrisci has justified the gargantuan price hikes by saying it sets the price based on the costs it incurs in developing the medication.<\/p>\n<p>httpv:\/\/www.youtube.com\/watch?v=nXMgPCyKPyY<\/p>\n<p><a target=\"_blank\" href=\"https:\/\/www.telesurtv.net\/english\/news\/Life-Saving-Cancer-Drug-Sees-1400-Price-Hike-20171227-0055.html\" >Go to Original \u2013 telesurtv.net<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The potentially life-saving medicine is used to treat patients suffering from brain tumors and Hodgkin&#8217;s lymphoma. While originally sold by Bristol-Myers Squib for decades for about US$50 a capsule, it now goes for US$768 per pill, thanks to startup NextSource\u2019s price hikes.<\/p>\n","protected":false},"author":4,"featured_media":104089,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-104088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-capitalism"],"_links":{"self":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts\/104088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/comments?post=104088"}],"version-history":[{"count":0,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts\/104088\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/media\/104089"}],"wp:attachment":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/media?parent=104088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/categories?post=104088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/tags?post=104088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}